SYK identified by bioinformatics analysis promotes the proliferation of multiple myeloma
Our findings establish SYK as a therapeutic target in MM, thereby facilitating the development of innovative treatment strategies.
Authors
- Peichun Li (ORCID: https://orcid.org/0000-0001-5659-1311)
- Fanggang Ren (ORCID: https://orcid.org/0000-0002-8204-698X)
- Minglin Hong
- Yanhong Tan (ORCID: https://orcid.org/0000-0002-6257-8655)
- Fengting Liang
- Shuo Li (ORCID: https://orcid.org/0000-0002-4880-6105)
- Ting Zhang (ORCID: https://orcid.org/0000-0002-2862-7644)
- Hongwei Wang (ORCID: https://orcid.org/0000-0001-7556-4634)
- Zhifang Xu (ORCID: https://orcid.org/0000-0003-0365-0976)
- Yaofang Zhang (ORCID: https://orcid.org/0000-0002-2054-6954)
- Ju Deng
Institutions
- Shanxi Medical University (CN)
- Second Hospital of Shanxi Medical University (CN)
- Shanxi University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Expert Review of Hematology
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1080/17474086.2025.2505724
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China